Inside Precision Medicine
Curetis, MGI to Co-Develop NGS Assays for Microbial Infection
![Curetis and BGI Group’s wholly-owned subsidiary MGI will partner to develop NGS in vitro diagnostic assays for microbial infection. The collaboration will combine Curetis’ Unyvero L4 Lysator (pictured) with MGI's SP100 Sample Preparation System and MGISeq NGS Sequencers. [Source: Curetis]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1244.jpeg "Curetis, MGI to Co-Develop NGS Assays for Microbial Infection")
![MedGenome has raised $30M in Series C financing toward advancing biomarker discovery programs and its OncoPept™ cancer immunotherapy biomarker solutions. [Source: 3desc/Fotolia]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1224.jpeg "MedGenome Completes $30M Series C Financing")
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.
Terms of ServicePrivacy Policy
